- Walgreens expanding scope of retail pharmacy experience and services heading into fiscal 2014
- Bloomberg: Greg Wasson joins thought leaders to discuss the state of health care in the United States
- Rite Aid posts third consecutive quarterly profit as company expands Wellness+
- CNNMoney sits down with Walgreens chief to discuss future of health care and what it means for pharmacy
- On the heels of Q3, Walgreens outlines shift in front-end strategy and pharmacy tailwinds looking forward
ROCKVILLE, Md. — Catalyst Rx, the pharmacy benefits management subsidiary of Catalyst Health Solutions, on Friday took out a full-page ad in the Wall Street Journal touting the value of a Walgreens pharmacy to a large healthcare payer. Catalyst also released a case study touting that value, according to a DrugChannels.net report.
According to that case study, Walgreens achieved a generic utilization rate of 69% versus 67.7% for all other chains in the area, resulting in a cost-per-script savings of $3.30.
"Excluding Walgreens from the case study client pharmacy network would cause significant member disruption, create potential gaps in patient care and impact costs to the client, its employees, retirees and their dependents," Catalyst Rx stated. "As with all of our participating pharmacy partners, we recognize the services and the value delivered by Walgreens to its local community residents and are pleased to continue to include them in our network in 2012."
For a copy of the case study, click here.
Catalyst Rx in June completed its acquisition of Walgreens' pharmacy benefit management subsidiary.